key: cord-0975859-w6mtd2hy authors: Vitacca, Michele; Salvi, Beatrice; Steinhilber, Gundi; Mineni, Michela; Comini, Laura; Paneroni, Mara title: Laboratory activity testing the lung function during 16 months of the Covid-19 pandemic: lung function laboratory reconfiguration after Covid-19 date: 2022-02-07 journal: Pulmonology DOI: 10.1016/j.pulmoe.2022.01.013 sha: c8082c55452e299951b1f07769b0da9a0809c3fa doc_id: 975859 cord_uid: w6mtd2hy nan Since March 2020, because of the SARS CoV2 correlated pandemic, 2 all lung function testing laboratories (LFTLs) have been reconfigured 3 and examinations reduced or suspended. This reorganization has forced to changes in tasks, roles, protocols and scheduling of the LFTLs, starting from the initial proposed indications and suggestions. 4, 5 This descriptive report aims to explore and measure, retrospectively, the impact of the Patients attended our outpatient LFTL service having been referred by their general practitioner or by an external pulmonologist for lung and disability assessment. Inpatients were transferred to our hospital directly or within 30 days following an acute illness, that had previously required either acute hospital care or home management by the general practitioner. Our LFTL has undergone a profound transformation as imposed by the Italian Health Authorities and was interrupted from March to May 2020 before re-opening; there was no reduction or increase in human resources (doctors and technicians). Specific instructions and suggestions were introduced during the pandemic, following Scientific Societies 4,5 , for organization, waiting areas, re-organizing testing, tests procedure, increase testing times, need for more consumables, use of UV sanitization, chemical sanitization of the plethysmography box between patients, use of antimicrobial filters during maneuvers, protection of healthcare workers during lung function testing, training in use of medical masks such as FFP2 9 , frequent hand hygiene, interpersonal distancing and re-indications for lung function tests. More space in waiting rooms, dedicated slots for exams, differentiation of spirometers, increased ventilation times to face the risk of contagion and requests for a negative swab for patients before accessing the LFTL have also been provided. To reduce the spread of the severe acute respiratory Coronavirus 2 syndrome, many LFTLs have been closed or significantly reduced their testing capacity, 3 while respiratory physicians, researchers, and administrators have begun to consider how different options to conventional pulmonary function testing could be integrated into the patients'care. 3 Since the pandemic beginning, scientific Societies have had a justified position of extreme caution in the execution of LFT. 4, 5 The same Societies have provided a set of information about the risks and recommendations for LFT, updating them continuously during the pandemic time, 4,5 and giving the possibility for a rapid reopening with maximum safety. 5 To the best of our knowledge, this is the first Italian study showing what has changed in terms of quantity and quality since the reopening of a lung function testing laboratory after the deep Covid-19 crisis. Despite the strong perplexities, fear and resistance for a full resumption of activity, our service was able to restart its mission in maximal safety; the substantial restoration of the volumes of activity, even in a progressive way during the months of reopening, has allowed us to give significant answers especially to the strong demand for outpatient diagnostics. It is interesting to note how the requests received at our service have been deeply influenced by the post Covid-19-19 problems as demonstrated by the strong increase in testing for lung volume diffusion, one of the more significant and useful tests for post Covid-19 sequelae. 10, 11, 12 DLCO acquired in fact relevance due to its specific capacity to evaluate interstitial lung disease impairment and due to easy and non-invasive execution of the maneuver requested. 10, 11, 12 Our data have demonstrated that the maximum pre-caution/safety and the essential need to measure the lung function may coexist, independently from the kind of respiratory disease. Furthermore, our data may be of interest for doctors and health organizers to develop a policy that provides strategies of re-opening and re-organisation of lung function laboratories; at the same time, it may be of interest to focus on which kind of performance (inpatient vs outpatient, types of respiratory function tests) is more requested during a pandemic time. Our results have highlighted the impact of the SARS-CoV-2 pandemic on a lung function testing laboratory facility in a typical Italian rehabilitative hospital, showing a significant change in terms of quantity, modality and quality activities. Lung function testing laboratory should be considered a key component in the health follow up, planning a response to a respiratory pandemic crisis. COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems COVID-19-19 coronavirus pandemic Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic 1 (Respiratory function technologists /Scientists) Lung function testing during COVID-19 pandemic and beyond /ERS_91_Statement_on_lung_function_during_COVID-19_Final_with_Contributors.pdf Noninvasive ventilation during weaning from prolonged mechanical ventilation Physiological and clinical characteristics of patients with COPD admitted to an inpatient pulmonary rehabilitation program: A real-life study Pulmonary Rehabilitation in Patients Recovering from COVID-19 Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other viruses Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology The authors thank Adriana Olivares for technical assistance. This work was supported by the "Ricerca Corrente" funding scheme from the Italian Ministry The authors have no conflicts of interest to declare. Legend: Data shown as number and (%). Abbreviations: LFTL: lung function testing laboratory; FEV 1 = forced expiratory volume at first second; RV = residual volume; DLCO = lung carbon monoxyde diffusion; PaO 2 = arterial oxygen tension; FiO 2 = inspiratory fraction of oxygen; *p= 0.0178, # p= 0.0001; @ p< 0.0001; + p = 0.1376 for comparison between total values of each evaluation collected during pandemic and pre-pandemic.